Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Pasha

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Expert Review of Cardiovascular Therapy|February 11, 2021
Clinical outcomes of patients with diabetes mellitus and acute ST-elevation myocardial infarction following fibrinolytic therapy: a nationwide inpatient sample (NIS) database analysisWaqas Ullah, Sameer Saleem, Salman Zahid, et al.
Canadian Journal of Physiology and Pharmacology|April 3, 2002
Calmodulin-dependent cyclic nucleotide phosphodiesterase in an experimental rat model of cardiac ischemia-reperfusionRakesh Kakkar, Dallas P Seitz, Rani Kanthan, et al.
Journal of the American Heart Association|May 25, 2021
Coronary Heart Disease Risk Associated with Primary Isolated Hypertriglyceridemia; a Population-Based StudySeyedmohammad Saadatagah, Ahmed K Pasha, Lubna Alhalabi, et al.
Blood Cancer Journal|July 26, 2012
The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AMLV Novotny-Diermayr, S Hart, K C Goh, et al.
Journal of Thrombosis and Thrombolysis|August 31, 2021
Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: a systematic review and meta-analysisAhmed K Pasha, Muhammad Umer Siddiqui, Muhammad Danial Siddiqui, et al.
Hellenic Journal of Nuclear Medicine|February 14, 2015
Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteriesAhmed K Pasha, Mateen Moghbel, Babak Saboury, et al.
Thrombosis Research|October 14, 2021
Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19Ahmed K Pasha, Robert D McBane, Rahul Chaudhary, et al.
Journal of Thrombosis and Thrombolysis|February 4, 2021
Calf vein thrombosis outcomes comparing patients with and without cancerAhmed K Pasha, Wiktoria Kuczmik, Waldemar E Wysokinski, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2022
Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysisWaqas Ullah, Salman Zahid, Harigopal Sandhyavenu, et al.
Mymensingh Medical Journal : MMJ|February 21, 2018
Study of Angiographic Relationship between Peripheral Arterial Diseases with the Involvement of Specific Coronary Artery LesionS A Habib, M N Islam, M F Rahman, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Expert Review of Cardiovascular Therapy|February 11, 2021
Clinical outcomes of patients with diabetes mellitus and acute ST-elevation myocardial infarction following fibrinolytic therapy: a nationwide inpatient sample (NIS) database analysisWaqas Ullah, Sameer Saleem, Salman Zahid, et al.
Canadian Journal of Physiology and Pharmacology|April 3, 2002
Calmodulin-dependent cyclic nucleotide phosphodiesterase in an experimental rat model of cardiac ischemia-reperfusionRakesh Kakkar, Dallas P Seitz, Rani Kanthan, et al.
Journal of the American Heart Association|May 25, 2021
Coronary Heart Disease Risk Associated with Primary Isolated Hypertriglyceridemia; a Population-Based StudySeyedmohammad Saadatagah, Ahmed K Pasha, Lubna Alhalabi, et al.
Blood Cancer Journal|July 26, 2012
The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AMLV Novotny-Diermayr, S Hart, K C Goh, et al.
Journal of Thrombosis and Thrombolysis|August 31, 2021
Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: a systematic review and meta-analysisAhmed K Pasha, Muhammad Umer Siddiqui, Muhammad Danial Siddiqui, et al.
Hellenic Journal of Nuclear Medicine|February 14, 2015
Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteriesAhmed K Pasha, Mateen Moghbel, Babak Saboury, et al.
Thrombosis Research|October 14, 2021
Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19Ahmed K Pasha, Robert D McBane, Rahul Chaudhary, et al.
Journal of Thrombosis and Thrombolysis|February 4, 2021
Calf vein thrombosis outcomes comparing patients with and without cancerAhmed K Pasha, Wiktoria Kuczmik, Waldemar E Wysokinski, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2022
Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysisWaqas Ullah, Salman Zahid, Harigopal Sandhyavenu, et al.
Mymensingh Medical Journal : MMJ|February 21, 2018
Study of Angiographic Relationship between Peripheral Arterial Diseases with the Involvement of Specific Coronary Artery LesionS A Habib, M N Islam, M F Rahman, et al.
Pageof 6